Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection.

DNA degradation is a fundamental problem for any gene therapy or genetic immunization approach, since destruction of incoming genes translates into loss of gene expression. To characterize the biology of DNA degradation after naked DNA injection, the location and levels of tissue nucleases were assessed. Extracts from the serum, kidney, and liver of mice had high levels of calcium-dependent endonuclease activity. High levels of acidic endonuclease activity were identified in the spleen, liver, kidney, and skin with little activity in skeletal or cardiac muscle. Relatively little exonuclease activity was observed in any tissue. The presence of endonucleases in the skin and muscle mediated degradation of 99% of naked DNA within 90 min of injection. This degradation most likely occurred in the extracellular space upstream of other cellular events. Despite this massive destruction, gross tissue nuclease levels did not determine skin-to-muscle transfection efficiency, or site-to-site transfection efficiency in the skin. While gross tissue nuclease levels do not appear to determine differences in transfection efficiency, the presence of robust tissue nuclease activity still necessitates that massive amounts of DNA be used to overcome the loss of 99% of expressible DNA. In addition to destroying genes, the nucleases may play a second role in genetic immunization by converting large plasmids into small oligonucleotides that can be taken up more easily by immune cells to stimulate CpG-dependent Th1 immune responses. For genetic immunization, vaccine outcome may depend on striking the right balance of nuclease effects to allow survival of sufficient DNA to express the antigen, while concomitantly generating sufficient amounts of immunostimulatory DNA fragments to drive Th1 booster effects. For gene therapy, all nuclease effects would appear to be negative, since these enzymes destroy gene expression while also stimulating cellular immune responses against transgene-modified host cells.

[1]  W. Strauss Preparation of Genomic DNA from Mammalian Tissue , 1998, Current protocols in molecular biology.

[2]  S. Wilton,et al.  Gene therapy and molecular approaches to the treatment of hereditary muscular disorders , 2000, Current opinion in neurology.

[3]  P. Saggau,et al.  Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. , 2000, Journal of biomedical materials research.

[4]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[5]  A. Eastman,et al.  The Cloning and Expression of Human Deoxyribonuclease II , 1998, The Journal of Biological Chemistry.

[6]  K. Suzuki,et al.  Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor , 1998, Gene Therapy.

[7]  K. Baker,et al.  Molecular cloning and characterization of human and murine DNase II. , 1998, Gene.

[8]  K. Iczkowski,et al.  Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. , 1998, Pancreas.

[9]  E. Aronica,et al.  Aurintricarboxylic acid prevents GLUR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Krieg,et al.  CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. , 1998, Journal of immunology.

[11]  R. Iida,et al.  Molecular Cloning of the cDNA Encoding Human Deoxyribonuclease II* , 1998, The Journal of Biological Chemistry.

[12]  M. Horwitz,et al.  On the mechanism of DNA transfection: efficient gene transfer without viruses , 1997, Gene Therapy.

[13]  A. Krieg,et al.  Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12 , 1997 .

[14]  C. Leclerc,et al.  The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. , 1997, Cellular immunology.

[15]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[16]  C. Pan,et al.  Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism. , 1997, Biochemistry.

[17]  T. Yasuda,et al.  Mouse deoxyribonuclease I (DNase I): Biochemical and immunological characterization, cDNA structure and tissue distribution , 1997, Biochemistry and molecular biology international.

[18]  S. Johnston,et al.  Biological features of genetic immunization. , 1997, Vaccine.

[19]  R. Webster,et al.  Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. , 1997, Journal of immunology.

[20]  Z. Xiang,et al.  Immune response to neonatal genetic immunization. , 1997, Virology.

[21]  X. Song,et al.  Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation , 1996 .

[22]  A. Krieg,et al.  Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. , 1996, Journal of immunology.

[23]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[24]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Szoka,et al.  Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. , 1996, Gene therapy.

[26]  A. Krieg,et al.  Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. , 1996, Antisense & nucleic acid drug development.

[27]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.

[28]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[29]  F. Hobbs,et al.  Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides. , 1995, Molecular pharmacology.

[30]  M. Peitsch,et al.  Genomic organisation and expression of mouse deoxyribonuclease I. , 1995, Biochemical and biophysical research communications.

[31]  K. Bleicher,et al.  Enzymatic degradation of various antisense oligonucleotides: monitoring and fragment identification by MECC and ES-MS. , 1995, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity.

[32]  E. Raz,et al.  Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Trainor,et al.  Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. , 1994, Molecular pharmacology.

[34]  H L Robinson,et al.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Rundell,et al.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. , 1993, Human gene therapy.

[36]  J. Hansen,et al.  Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay. , 1993, Journal of virological methods.

[37]  A. Eastman,et al.  Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. , 1993, Archives of biochemistry and biophysics.

[38]  A. Krieg,et al.  Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. , 1993, Antisense research and development.

[39]  R. Bassel-Duby,et al.  A 40-kilodalton protein binds specifically to an upstream sequence element essential for muscle-specific transcription of the human myoglobin promoter , 1992, Molecular and cellular biology.

[40]  G. Acsadi,et al.  Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. , 1992, Human molecular genetics.

[41]  K Zatloukal,et al.  Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Ecker,et al.  Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. , 1991, Nucleic acids research.

[43]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Pisetsky,et al.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. , 1991, Journal of immunology.

[45]  S. Johnston,et al.  Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Acsadi,et al.  Direct gene transfer and expression into rat heart in vivo. , 1991, The New biologist.

[47]  K. Mechtler,et al.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[49]  D. Tidd,et al.  Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups. , 1989, British Journal of Cancer.

[50]  H. Jörnvall,et al.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. , 1989, The Journal of biological chemistry.

[51]  M. Yamanaka,et al.  Purification and properties of acid deoxyribonucleases of human gastric mucosa and cervix uteri. , 1974, The Journal of biological chemistry.

[52]  G. Bernardi,et al.  Studies on acid deoxyribonuclease. VII. Conformation of three nucleases in solution. , 1970, Archives of biochemistry and biophysics.

[53]  G. Bernardi,et al.  STUDIES ON ACID DEOXYRIBONUCLEASE. II. ISOLATION AND CHARACTERIZATION OF SPLEEN-ACID DEOXYRIBONUCLEASE. , 1964, Biochemistry.

[54]  R. Winkelmann,et al.  Squamous cell carcinoma produced by ultraviolet light in hairless mice. , 1963, The Journal of investigative dermatology.